The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit

Journal of Hospital Infection

Volumn 48, Issue 3, 2001, Pages 186-192

  Cox, R A ^a   Rao, P ^a   Brandon Cox, C ^a  

^a KETTERING GENERAL HOSPITAL   (United Kingdom)

Author keywords

Disease outbreak; Infection control; Monoclonal antibodies; Premature infant; Respiratory syncytial virus infection

Indexed keywords

MONOCLONAL ANTIBODY; PALIVIZUMAB;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; INFECTION CONTROL; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0034913596     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2001.1002     Document Type: Article

References (21)

1. Respiratory syncytial virus: An underestimated cause of respiratory infection, with prospects for a vaccine
2. Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission
3. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions
4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus in high risk infants
5. Recovery of cytopathogenic agent from chimpanzees with coryza
6. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA): I. Isolation, properties and characterization
7. Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults
8. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus
9. Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by a commercial enzyme immunoassay
10. Detection of respiratory syncytial virus in clinical specimens by viral culture, direct and indirect immunofluorescence, and enzyme immunoassay
11. Respiratory syncytial virus infection of the newborn
12. Respiratory syncytial virus in special care nursery
13. Respiratory syncytial virus infections in infants: Quantitation and duration of shedding
14. Quantitative shedding patterns of respiratory syncytial virus in infants
15. Prophylactic administration of respiratory syncytial virus immune globulin to high risk infants and young children
16. Immunoglobulin for preventing respiratory syncytial virus infection
17. Preventing respiratory syncytial virus bronhiolitis
18. RSV prevention
19. Hospitalisation for RSV infection in ex-preterm infants - Implications for use of RSV immune globulin
20. Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort
21. Cost-effectiveness of respiratory syncytial virus prophylaxis among pre-term infants